Timolol: all 81 studies that test it
Page 1 of 1. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.
- The Effects of Timolol On Healing and Cosmesis of Mohs Scalp Wounds: An Open Label TrialNot yet recruitingNCT07583862Phase 2
- Efficacy of 0.5% Topical Timolol Eye Drops in the Treatment of Post-Inflammatory Erythema Following Acne VulgarisRecruitingNCT07474883Early Phase 1
- Efficacy and Safety of Topical Timolol in Secondary Intention Surgical Wounds HealingNot yet recruitingNCT07384767Phase 2
- Topical 0.5% Timolol Solution for Healing Lower Extremity WoundsRecruitingNCT06941467Phase 1
- Efficacy and Safety of Add-on Timolol for EGFR-TKI and ALK-TKI Induced ParonychiaRecruitingNCT06643416Phase 3
- Efficacy and Safety of Timolol for TKI Induced ParonychiaRecruitingNCT06140186Phase 3
- A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in NewbornRecruitingNCT01873131Not applicable
- Timolol Gel for Epistaxis in Hereditary Hemorrhagic TelangiectasiaCompletedNCT04139018Phase 2Results posted
- A Randomized Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of MigraineCompletedNCT03836664Phase 2Results posted
- Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography StudyCompletedNCT03323164Phase 4Results posted
- Beta Adrenergic Antagonist for the Healing of Chronic DFUCompletedNCT03282981Phase 3Results posted
- A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular HypertensionCompletedNCT02742649Phase 1/2Results posted
- Timolol Eye Drops in the Treatment of Acute Migraine HeadacheTerminatedNCT02630719Not applicableResults posted
- Stop Retinal Ganglion Cell Dysfunction StudyTerminatedNCT02390284Phase 3Results posted
- Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular HypertensionCompletedNCT02097719Phase 4Results posted
- An Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular HypertensionCompletedNCT01881126Phase 4Results posted
- Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of ConceptCompletedNCT01752049Phase 1/2Results posted
- Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01241240Phase 3Results posted
- Safety and Efficacy of Brimonidine Tartrate/Timolol Fixed Combination in Patients With Glaucoma or Ocular HypertensionCompletedNCT01229462Not applicableResults posted
- Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01217606Phase 3Results posted
- Safety and Pharmacodynamics Study of AGN-207281 Ophthalmic Solutions Compared With Timolol Ophthalmic Solution or Placebo in Patients With Ocular Hypertension or Primary Open-Angle GlaucomaCompletedNCT01215786Phase 1Results posted
- Intraocular Pressure and Ocular Perfusion Pressure of Cosopt in Normal Tension GlaucomaCompletedNCT01175902Not applicableResults posted
- Safety and Efficacy of Bimatoprost Timolol Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular HypertensionCompletedNCT01068964Not applicableResults posted
- Patient Satisfaction With Timolol in Subjects With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00804648Phase 4Results posted
- Comparing Efficacy and Safety of Combigan With Timolol Adjunctive to Xalatan in Glaucoma or Ocular Hypertension SubjectsCompletedNCT00735449Phase 4Results posted
- Circadian Rhythms of Aqueous Humor Dynamics in HumansCompletedNCT00572936Phase 2Results posted
- Adherence Assessment With Travalert Dosing AidCompletedNCT00508469Phase 4Results posted
- Comparison of Fractional CO2 Laser Monotherapy and Its Combination With Either Topical Vitamin C or Topical Timolol in the Treatment of Post-Acne Erythema: A Split Face StudyCompletedNCT07884565Phase 2
- Prophylactic Use of Timolol Maleate to Prevent Intraocular Pressure Elevation After Nd:YAG Laser Posterior CapsulotomyCompletedNCT07729189Not applicable
- Evaluate the Safety, Tolerance, and Pharmacokinetic Profiles of Timolol Maleate GelCompletedNCT06824948Phase 1
- Timolol Maleate Gel for the Treatment of Infantile HemangiomaCompletedNCT06677853Phase 2/3
- How Much Does Reduced Dosing of Latanoprost and Dorzolamide-timolol Affect Pressure?TerminatedNCT06369077Phase 4
- Dorzolamide+Timolol Multidose Preservative-free vs Dorzolamida+Timolol BAK Preserved Efficacy and SafetyCompletedNCT05857267Phase 4
- 24-hour Efficacy and Tolerability of the Tafluprost-timolol Fixed Association Without Preservatives in Glaucomatous or Ocular Hypertensive Patients Already Treated With Latanoprost Preserved With BAK. A Prospective, Open Study of 3 Months Duration.Status unknownNCT05299593Phase 4
- The Efficacy of Topical Timolol Combined With Cryotherapy in EGFR Inhibitors-induced Paronychia - a Double-blinded, Intrapatient Left-to-right Controlled StudyCompletedNCT05165082Not applicable
- Topical Timolol: a Comparison of Surgical OutcomesStatus unknownNCT05114239Phase 2
- Interval Intraocular Pressure in Intravitreal Injection StudyCompletedNCT04868175Not applicable
- Aqueous Humor Dynamic Components That Determine Intraocular Pressure VarianceCompletedNCT04412096Phase 4
- Evaluation of the Efficacy of Captopril Versus Propranolol and Timolol as a Treatment of Infantile Capillary HemangiomaStatus unknownNCT04288700Phase 4
- Efficacy and Safety of Latanoprost/Timolol for Primary Open Angle GlaucomaStatus unknownNCT04098861Phase 4
- Choroidal Thickness and Its Correlations With Ocular Parameters in Primary Open-angle GlaucomaCompletedNCT03966560Phase 4
- Study Comparing the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density and Visual AcuityCompletedNCT03931317Not applicable
- Effectiveness and Safety of Timolol and Dorzolamide Loaded Contact LensesCompletedNCT02852057Phase 1
- 24-hour Efficacy and Ocular Surface With Talfuprost and Triple Combined TherapyCompletedNCT02802137Phase 4
- Timolol for the Treatment of Acne and RosaceaCompletedNCT02774590Phase 1
- Topical Timolol for Infantile Hemangioma in Early Proliferative PhaseCompletedNCT02731287Phase 2
- Evaluation of a New Method for Instilling Eye DropsCompletedNCT02697318Early Phase 1
- Pupillary Response After Glaucoma MedicationCompletedNCT02522039Not applicable
- Efficacy of a Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) - (TEMPO)CompletedNCT02484716Phase 2
- Topical Timolol Benefit in Venous UlcersCompletedNCT02422017Phase 2
- The Effect of Topical Treatment With Combigan Compared to Timolol and Brimonidine on Pupil DiameterStatus unknownNCT02214680Phase 2
- Comparison of the Effects of Bimatoprost and a Fixed Combination of Latanoprost and Timolol on 24-hour Blood and Ocular Perfusion PressuresCompletedNCT02154217Phase 3
- Topical Timolol Gel for the Treatment of Infantile HemangiomasCompletedNCT02145884Phase 2
- Effect of Antiglaucoma Agents on Short Term Intraocular Pressure Fluctuations After Intravitreal Bevacizumab InjectionCompletedNCT02140450Not applicable
- Impact of Timolol/Dorzolamide Therapy on Autoregulation in Glaucoma PatientsCompletedNCT02053298Phase 4
- Effect of Topical Glaucoma Therapy on Tear Film Stability in Healthy SubjectsTerminatedNCT01746602Phase 3
- 24-hour Control of Intraocular Pressure (IOP) in Ocular HypertensionCompletedNCT01655758Phase 4
- Treatment Study for Ischemic Optic Neuropathy With Opthalmic Timolol Maleate 0.5%WithdrawnNCT01607671Phase 1
- Effect of Prophylactic Aqueous Suppression on Hyperencapsulation of Ahmed Glaucoma ValvesStatus unknownNCT01535768Phase 4
- Treatment of Port-wine Mark in Sturge-Weber Syndrome Using Topical TimololTerminatedNCT01533376Phase 1
- Effect of Timolol on Refractive Outcomes in Eyes With Myopic Regression After LASIK: a Randomized Clinical TrialCompletedNCT01506635Not applicable
- Efficacy and Safety Study of Combigan and 0.5% Timoptic in Normal Tension GlaucomaStatus unknownNCT01446497Phase 4
- Timolol Option for Ulcerated Hemangiomas (TOUCH Trial)WithdrawnNCT01408056Phase 2
- Topical Timolol for the Treatment of Benign Vascular Periocular LesionsWithdrawnNCT01250457Phase 4
- A Comparison of the Effect of Dorzolamide and Timolol on Optic Disk Blood Flow in Patients With Open Angle GlaucomaCompletedNCT00991822Phase 2/3
- 24-hr Intraocular Pressure Control With Dorzolamide/Timolol vs the Brimonidine/Timolol Fixed CombinationCompletedNCT00972257Phase 4
- Evaluation of the iStent Versus Two Ocular Hypotensive Agents in Patients With Primary Open-angle Glaucoma (POAG)CompletedNCT00913029Phase 4
- Interaction Study of Timolol Eye Drops and Paroxetine CapsulesCompletedNCT00879099Phase 1
- The International Collaborative Exfoliation Syndrome Treatment StudyStatus unknownNCT00804115Not applicable
- Comparison of Latanoprost Vs. TimololTerminatedNCT00579969Phase 2
- Patient Preference StudyCompletedNCT00576342Phase 3
- A Study to Evaluate the Effectiveness of Cosopt® as First Line Therapy (MK-0507A-153)CompletedNCT00546286Phase 3
- 24-hour Study of Dorzolamide/Timolol and Latanoprost/Timolol Fixed CombinationsCompletedNCT00397241Phase 4
- Beta Blocker for Chronic Wound HealingTerminatedNCT00368602Phase 2
- A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00326092Phase 2
- Study of Medical Treatment of Low-Pressure (Normal Tension) GlaucomaCompletedNCT00317577Phase 2
- A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With GlaucomaCompletedNCT00277498Phase 3
- Effects of Common Topical Glaucoma Therapy on Optic Nerve Head Blood Flow Autoregulation During Increased Arterial Blood Pressure and Artificially Elevated Intraocular Pressure in Healthy HumansWithdrawnNCT00275756Not applicable
- A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With GlaucomaCompletedNCT00159653Phase 3
- Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours (0507A-137)(COMPLETED)CompletedNCT00108017Phase 3
- Prevention of Esophageal Varices by Beta-Adrenergic BlockersCompletedNCT00006398Phase 3